SCHEMBL28480893

SCHEMBL28480893

C1=CONC(N2CCNCC2)=C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 7/20 0.35
HTR3E A5X5Y0 2/20 0.35
HTR3B O95264 2/20 0.35
HTR3A P46098 2/20 0.35
HTR3D Q70Z44 2/20 0.35
HTR3C Q8WXA8 2/20 0.35
SIGMAR1 Q99720 2/20 0.35
ADRB2 P07550 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
BPTF Q12830 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
NCF1 P14598 1/20 0.33
PLD1 Q13393 1/20 0.33
LMNA P02545 1/20 0.31
HRH1 P35367 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5866411 0.82
SCHEMBL30724578 0.81 LMNA (0.35) ALDH1A1KDM4ELMNA
SCHEMBL1420015 0.67 ADRB1 (0.36) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL17067817 0.67 KDM4E (0.42) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL28033389 0.65 ADRB1 (0.35) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4703910 0.65 ADRB1 (0.35) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL28705412 0.63 ADRB1 (0.35) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL27668244 0.63 ADRB1 (0.33) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5062726 0.63 MGLL (0.33)
SCHEMBL6631277 0.62 CHRNB2 (0.37) HTR3AHRH1CASP1CASP4CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113329999-A Novel substituted quinoline-8-carbonitrile derivatives having androgen receptor degrading activity and uses thereof 冰洲石生物科技公司 2021-08-31 CN claimed
CN-112154146-A Serine threonine kinase (AKT) degradation/disruption compounds and methods of use 西奈山伊坎医学院 2020-12-29 CN claimed
CN-110741004-B Compounds and methods for rapid accelerated targeted degradation of fibrosarcoma polypeptides 阿尔维纳斯运营股份有限公司 2023-10-17 CN disclosed
CN-107108698-B Macrocyclic peptides as immunomodulators 百时美施贵宝公司 2022-04-29 CN disclosed
CN-111925341-A Preparation method of piperazine 山东达民化工股份有限公司 2020-11-13 CN disclosed
CN-111868146-A Composite materials comprising mechanical ligands 纳诺科尔有限公司 2020-10-30 CN disclosed
CN-110997679-A Bicyclic compounds and methods of use 拜欧赛里克斯公司 2020-04-10 CN disclosed